BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3856238)

  • 1. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.
    Kappas A; Simionatto CS; Drummond GS; Sassa S; Anderson KE
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):896-900. PubMed ID: 3856238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.
    Simionatto CS; Anderson KE; Drummond GS; Kappas A
    J Clin Invest; 1985 Feb; 75(2):513-21. PubMed ID: 3838318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects.
    Berglund L; Angelin B; Blomstrand R; Drummond G; Kappas A
    Hepatology; 1988; 8(3):625-31. PubMed ID: 3371880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism.
    Drummond GS; Galbraith RA; Sardana MK; Kappas A
    Arch Biochem Biophys; 1987 May; 255(1):64-74. PubMed ID: 3592668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver.
    Sardana MK; Kappas A
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2464-8. PubMed ID: 3470805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin.
    Kappas A; Drummond GS; Simionatto CS; Anderson KE
    Hepatology; 1984; 4(2):336-41. PubMed ID: 6546735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.
    Berglund L; Angelin B; Hultcrantz R; Einarsson K; Emtestam L; Drummond G; Kappas A
    Gut; 1990 Aug; 31(8):899-904. PubMed ID: 2387514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.
    Drummond GS; Kappas A
    J Clin Invest; 1986 Mar; 77(3):971-6. PubMed ID: 3753986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.
    Kappas A; Drummond GS; Sardana MK
    J Clin Invest; 1985 Jan; 75(1):302-5. PubMed ID: 3965510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.
    Drummond GS; Kappas A
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6466-70. PubMed ID: 6947237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase.
    Anderson KE; Simionatto CS; Drummond GS; Kappas A
    J Pharmacol Exp Ther; 1984 Feb; 228(2):327-33. PubMed ID: 6546399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical properties of the heme oxygenase inhibitor, Sn-protoporphyrin. Interactions with apomyoglobin and human serum albumin.
    Breslow E; Chandra R; Kappas A
    J Biol Chem; 1986 Mar; 261(7):3135-41. PubMed ID: 3753975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin.
    Chernick RJ; Martasek P; Levere RD; Margreiter R; Abraham NG
    Hepatology; 1989 Sep; 10(3):365-9. PubMed ID: 2759552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.
    Drummond GS; Kappas A
    J Exp Med; 1982 Dec; 156(6):1878-83. PubMed ID: 6897419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tin protoporphyrin on the excretion rate of carbon monoxide in newborn rats after hematoma formation.
    Posselt AM; Cowan BE; Kwong LK; Vreman HJ; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):650-4. PubMed ID: 3839847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc . protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat.
    Maines MD
    Biochim Biophys Acta; 1981 Mar; 673(3):339-50. PubMed ID: 6894392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of exogenous heme as carbon monoxide and biliary heme in adult rats after tin protoporphyrin treatment.
    Hintz SR; Kwong LK; Vreman HJ; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1987; 6(2):302-6. PubMed ID: 3694354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tin (IV)-protoporphyrin-IX on bilirubin production and excretion in the rat.
    Whitington PF; Moscioni AD; Gartner LM
    Pediatr Res; 1987 May; 21(5):487-91. PubMed ID: 3588088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model.
    Drummond GS; Kappas A
    Science; 1982 Sep; 217(4566):1250-2. PubMed ID: 6896768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins.
    Drummond GS; Rosenberg DW; Kappas A
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1170-5. PubMed ID: 1551526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.